Pharmaceutical giant Biogen agrees to pay $900 million to settle federal whistleblower lawsuit

US 27-9-2022 UPI 28
U.S. drugmaker Biogen will pay $900 million to settle a federal whistleblower lawsuit that alleged the company overbilled the nation's health insurance programs and paid doctors under the table to prescribe its drugs. 
Read The Rest at UPI- (opens a new tab)